
Intellia Therapeutics Investors Urged to Seek Counsel Before Crucial Deadline in Securities Lawsuit
Rosen Law Firm encourages Intellia Therapeutics investors to secure counsel before selling shares, citing potential securities law violations. The law firm is investigating claims of misrepresentation and omission in Intellia's public statements.